Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Inovio Pharma (NQ: INO )

9.000 USD -0.100 (-1.10%)
Official Closing Price Updated: 7:59 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Inovio Pharma

< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
Inovio Pharmaceuticals and Roche Initiate Clinical Trial for Inovio's DNA Immunotherapy to Treat Chronic Hepatitis B Infection
From GlobeNewswire News Releases
All Penny Stocks.com News: More Strides Made in Protecting Against Ebola Virus
Mississauga, ON -- (ReleaseWire) -- 04/09/2015 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled "More Strides Made in Protecting Against Ebola... 
From SBWire - Latest Press Releases
Inovio Pharmaceuticals' HPV Immunotherapy Recognized as "Best Therapeutic Vaccine" by World Vaccine Congress
Inovio's Co-Founder and Chair of Its Scientific Board -- Dr. David B. Weiner's Lab Named "Best Academic Research Team" 
From GlobeNewswire News Releases
Critical Alerts For Inovio Pharmaceuticals, Perrigo Co., Weibo, Regulus Therapeutics and Qihoo 360 Technology Released By InvestorsObserver
From PR Newswire
Leading Biotech Companies Seek Biologic Treatments for Rare Diseases Utilizing Viable Therapeutic Approach - Company Receives FDA Orphan Drug Designation for Bryostatin
From PR Newswire
Inovio Pharmaceuticals HPV Immunotherapy Activates Robust In Vivo T Cell Responses in Head & Neck Cancer Patients
DNA-Based Immunotherapy Generates Strong Immune Responses Similar to Those in Patients Treated for Cervical Dysplasia 
From GlobeNewswire News Releases
Inovio Pharmaceuticals Selected by DARPA to Lead a $45 Million Program to Expedite Development of Novel Products to Prevent and Treat Disease Caused by Ebola
Funding Will Accelerate Development of Inovio's DNA-Based Monoclonal Antibodies That Could Offer Product Development, Manufacturing, Scale-Up and Dosing Benefits 
From GlobeNewswire News Releases
Research & Clinical Trials for Prevention of Neurodegeneration Search for Viable Therapeutic Approach for the Treatment of Severe Alzheimer's Disease
From PR Newswire
Critical Alerts For Inovio Pharmaceuticals, Arrowhead Research, 3D Systems, Stratasys and Pixelworks Released By InvestorsObserver
From PR Newswire
Inovio Pharmaceuticals to Present at Alliance Regenerative Medicine's 2015 Regen Med Investor Day
From GlobeNewswire News Releases
Inovio Pharmaceuticals Appoints Scott M. White, M.D. Vice President, Clinical Development -- Infectious Diseases
From GlobeNewswire News Releases
Critical Alerts For Inovio Pharmaceuticals, Kandi Technologies, Skyworks Solutions Released By InvestorsObserver
From PR Newswire
Advances in Biotech Expanded Studies Lead to Cutting-Edge Therapeutic Treatments - Company Announces Positive Final Results in Treatment for Alzheimer's Disease
From PR Newswire
Inovio Pharmaceuticals and Academic Collaborators Receive $16 Million HIV Grant From National Institute of Allergy and Infectious Diseases
From GlobeNewswire News Releases
Inovio Pharmaceuticals Reports 2014 Fourth Quarter and Year End Financial Results
DNA-Based Active Immunotherapy Achieves Industry Milestone With Clinically Relevant Efficacy Via T Cell Activation in Large Controlled Study 
From GlobeNewswire News Releases
Cel-Sci's Cancer Immunotherapy In Phase III Is Value Opportunity
Tags Investor Relations
From ACCESSWIRE
T-Bird Pharma Inc. Announces Partnership with Medna Biosciences Inc.
From PR Newswire
Inovio Pharmaceuticals to Report Fourth Quarter and Year End 2014 Financial Results on March 16, 2015
From GlobeNewswire News Releases
Inovio Pharmaceuticals Welcomes Nancy Wysenski to Its Board of Directors
From GlobeNewswire News Releases
Critical Alerts For Inovio Pharmaceuticals, Dollar Tree, Intrexon, Harley-Davidson and HomeAway Released By InvestorsObserver
From PR Newswire
Critical Alerts For Inovio Pharmaceuticals, Pixelworks, Goldman Sachs, Sears Holdings and Cheniere Energy Released By InvestorsObserver
From PR Newswire
U.S. Congressman Patrick Meehan to Present Keynote Address at 22nd Annual Groundhog Investment Forum
From Business Wire News Releases
Inovio Pharmaceuticals to Present at Upcoming Investor Conferences
From GlobeNewswire News Releases
Investment Industry to Gather in Philadelphia at 22nd Annual Groundhog Day Investment Forum
From Business Wire News Releases
Inovio Pharmaceuticals Appoints Dr. Mark Gelder to Lead Clinical Development of Cervical Dysplasia and Cancer Programs
Dr. Gelder's Accomplishments Include Successful Development of Cancer Therapies at Pfizer, Wyeth and Bayer 
From PR Newswire
Critical Alerts For Juno Therapeutics Inc, Arrowhead Research, Bitauto Holdings, Intrexon and Inovio Pharmaceuticals Released By InvestorsObserver
From PR Newswire
Inovio Pharmaceuticals' CEO to Present at 2015 Biotech Showcase Conference
From PR Newswire
Inovio Pharmaceuticals HIV Immunotherapy Shows Characteristics Considered Vital to Treating HIV
Phase I Trial Reveals DNA Immunotherapy Results Were Similar To HIV-Infected Patients Whose Disease Did Not Progress 
From PR Newswire
Inovio Pharmaceuticals Initiates DNA Immunotherapy Trial for Breast, Lung and Pancreatic Cancers
Active Immunotherapy Targets hTERT Gene Associated with 85% of Cancers 
From PR Newswire
Inovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology
Dr. Yang led Janssen's prostate cancer and solid tumor therapeutic area in the U.S. 
From PR Newswire
< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.